Africa Large Volume Parenterals (LVP) Market Targets $1,133 Million by 2024

The growth of the massive parenteral drug market is driven by the prevalence of chronic diseases such as cancer, HIV and other infectious diseases. The number of operations increased sharply. The risk of malnutrition increases. However, in parenteral administration, treatment and nutritional need drug administration and preference for high pathway of infection / allergic response are expected to hamper market growth. On the contrary, as the demand for palliative care services in Africa surges, it is anticipated that market expansion opportunities will be provided during the forecast period.

The Africa large volume parenterals (LVP) market was valued at $662 million in 2017, and is expected to reach $1,133 million by 2024, growing at a CAGR of 7.9% from 2018 to 2024. In terms of volume, the market garnered 291,095 thousand units in 2017, and is expected to reach 582,780 thousand units by 2024, growing with a CAGR of 10.4% from 2018 to 2024.

Request Sample of Africa Large Volume Parenterals (LVP) Market Report @ https://www.alliedmarketresearch.com/request-sample/4613

The parenteral route of drug administration refers to administration of the drug via the non-oral route. Large amounts of parenteral solutions are also called aqueous solutions. This includes solutions containing calcium solution, sodium chloride, Ringer's, sodium bicarbonate and other electrolytes, dextrose (glucose) and other sugar solutions, amino acids, peptides and other protein fraction solutions, solutions containing the above combinations and other plasma expanders.

Increase in prevalence of chronic diseases, rapid surge in number of surgeries, and rise in risk of malnutrition are the major factors that drive the growth of the Africa large volume parenterals (LVP) market. However, preference for enteral nutrition and high risk of infection/allergic reaction during a parenteral administration restrain the market growth. Conversely, increase in demand for palliative care services in Africa is expected to offer potential growth opportunities for the market in the near future.

On the basis of treatment type, fluid balance injections segment dominated the market in 2017 by garnering nearly two-thirds share, and is expected to maintain its dominance during the analysis period. This is attributed to the fact that fluid balance injections can be used for a broad customer base, including patients who are critically ill, septic, with major cardiac, liver or renal comorbidity, or after a major surgery.

Based on route of administration, the intravenous segment held the major market share of more than four-fifths in 2017, and is expected to dominate the market throughout the analysis period, since it is the fastest way to deliver large volume parenterals, as the drug is easily carried throughout the body with the help of circulation.

Send Enquiry on Africa Large Volume Parenterals (LVP) Market report @ https://www.alliedmarketresearch.com/purchase-enquiry/4613

Key Findings of the Africa Large Volume Parenterals Market:

• Intramuscular segment is expected to grow with a CAGR of 8.2% from 2018 to 2024.
• By treatment type, the nutritious injections segment is expected to grow at the highest CAGR of 9.1% from 2018 to 2024.
• The 500 ml capacity segment held a major share of more than four-fifths and three-fourths in terms of value and volume, respectively, in 2017, and is expected to maintain this trend throughout the analysis period.
• South Africa held a major share of more than one-fifth in the African market in 2017, and is expected to retain it throughout the analysis period.
• Namibia is expected to register a CAGR of 7.7% from 2018 to 2024.

Based on country, South Africa is expected to dominate the Africa LVP market during the analysis period. Furthermore, Namibia is expected to grow at the highest CAGR and offer lucrative opportunities to market players in the coming future.

About us

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.